These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 22397557)
1. Host genetics and invasive fungal diseases: towards improved diagnosis and therapy? Cunha C; Carvalho A Expert Rev Anti Infect Ther; 2012 Mar; 10(3):257-9. PubMed ID: 22397557 [No Abstract] [Full Text] [Related]
2. Early diagnosis of fungal infection in immunocompromised patients. Barnes RA J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i3-6. PubMed ID: 18063601 [TBL] [Abstract][Full Text] [Related]
3. Invasive mycoses: evolving challenges and opportunities in antifungal therapy. Introduction. Perfect JR Am J Med; 2012 Jan; 125(1 Suppl):S1-2. PubMed ID: 22196204 [No Abstract] [Full Text] [Related]
4. Prevention and treatment of invasive fungal diseases in neutropenic patients. Almyroudis NG; Segal BH Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476 [TBL] [Abstract][Full Text] [Related]
5. Immunogenetic profiling to predict risk of invasive fungal diseases: where are we now? Cunha C; Aversa F; Bistoni G; Casagrande A; Rodrigues F; Romani L; Carvalho A Immunol Invest; 2011; 40(7-8):723-34. PubMed ID: 21985302 [TBL] [Abstract][Full Text] [Related]
13. Empirical antifungal treatment: a valid alternative for invasive fungal infection. Vallejo C; Barberán J Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092 [TBL] [Abstract][Full Text] [Related]
14. The impact of the host on fungal infections. Perfect JR Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208 [TBL] [Abstract][Full Text] [Related]
15. Management of immunocompromised patients with evidence of an invasive mycosis. Walsh TJ Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563 [TBL] [Abstract][Full Text] [Related]
16. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300 [TBL] [Abstract][Full Text] [Related]
17. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. Metcalf SC; Dockrell DH J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716 [TBL] [Abstract][Full Text] [Related]
18. Zygomycetes and Pythium spp., an aquatic phycomycetes isolated from patients and their host defense mechanism. Tanphaichitra D; Srimuang S; Siristonpun Y J Chemother; 1989 Jul; 1(4 Suppl):931-3. PubMed ID: 16312710 [No Abstract] [Full Text] [Related]
20. Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy? de Pauw BE; Donnelly JP Clin Infect Dis; 2009 Apr; 48(8):1052-4. PubMed ID: 19281329 [No Abstract] [Full Text] [Related] [Next] [New Search]